Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis

A composition for the treatment or prevention of osteoporosis which comprises:

• (a) 75 to 200 parts of one or more phytoestrogen compounds, wherein the phytoestrogen compound is a coumestan or an isoflavone selected from the group consisting of daidzein, genistein, glycitein, daidzin, genistin, glycitin, an acetylated form thereof and mixtures thereof;
• (b) 0 to 100 parts of dried licorice root extract;
• (c) 300 to 600 parts of calcium contained in a biologically acceptable calcium salt;
• (d) 70 to 280 parts of magnesium contained in a biologically acceptable magnesium salt;
• (e) 4 to 25 parts of zinc contained in a biologically acceptable zinc salt;
• (f) 5 to 20 parts of beta-carotene;
• (g) 0.005 to 0.010 parts of Vitamin D as cholecalciferol;
• and
• (h) 6 to 12 parts of Vitamin E,
• in admixture with a biologically acceptable inert carrier.